Introduction: Buprenorphine was first marketed in the United States in 1985 as a Schedule V narcotic analgesic. Until recently, the only available buprenorphine product in the United States has been a low-dose (0.3 mg/ml) injectable formulation under t...
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.
Page Comments
Buprenorphine was first marketed in the United States in 1985 as a Schedule V narcotic analgesic. Until recently, the only available buprenorphine product in the United States has been a low-dose (0.3 mg/ml) injectable formulation under t...
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.